For in vitro qualitative detection of SARSCoV-2 nucleocapsid antigen in nasal swabs (NS) directly from individuals suspected of having COVID-19 after symptom onset. This test is provided for use by clinical laboratories or healthcare workers only. Home use is governed by the laws of each country. Not suitable for children under 3 years old.
Characteristics
• Clinical certification by an independent European clinical study.
• Rapid detection of SARS-COV-2 nucleocapsid antigen in less than 15 min
Greece
